001     154740
005     20240229123110.0
024 7 _ |a 10.1001/jamaoncol.2020.0292
|2 doi
024 7 _ |a pmid:32379279
|2 pmid
024 7 _ |a 2374-2437
|2 ISSN
024 7 _ |a 2374-2445
|2 ISSN
024 7 _ |a altmetric:81612927
|2 altmetric
037 _ _ |a DKFZ-2020-00994
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Fallah, Mahdi
|0 P:(DE-He78)b510b884502b619724039bf33fdae68a
|b 0
|e First author
|u dkfz
245 _ _ |a Determining the Appropriate Risk-Adapted Screening Age for Familial Breast Cancer-Reply.
260 _ _ |a Chicago, Ill.
|c 2020
|b American Medical Association
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1602766175_10922
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a 2020 Jun 1;6(6):934-935#EA:C120#LA:C120#
536 _ _ |a 313 - Cancer risk factors and prevention (POF3-313)
|0 G:(DE-HGF)POF3-313
|c POF3-313
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Mukama, Trasias
|0 P:(DE-He78)ef3f7c40c2c68936a43baab29d559371
|b 1
|u dkfz
700 1 _ |a Kharazmi, Elhamalsadat
|0 P:(DE-He78)e56510c7dedbff7a279ad76dad80eeda
|b 2
|e Last author
|u dkfz
773 _ _ |a 10.1001/jamaoncol.2020.0292
|0 PERI:(DE-600)2810928-4
|n 6
|p 934-935
|t JAMA oncology
|v 6
|y 2020
|x 2374-2437
909 C O |o oai:inrepo02.dkfz.de:154740
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)b510b884502b619724039bf33fdae68a
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)ef3f7c40c2c68936a43baab29d559371
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-He78)e56510c7dedbff7a279ad76dad80eeda
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-313
|2 G:(DE-HGF)POF3-300
|v Cancer risk factors and prevention
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2020
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b JAMA ONCOL : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a IF >= 20
|0 StatID:(DE-HGF)9920
|2 StatID
|b JAMA ONCOL : 2017
920 1 _ |0 I:(DE-He78)C120-20160331
|k C120
|l Präventive Onkologie
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C120-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21